Correlation Between Biotechnology Ultrasector and Icon Information

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Icon Information at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Icon Information into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Icon Information Technology, you can compare the effects of market volatilities on Biotechnology Ultrasector and Icon Information and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Icon Information. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Icon Information.

Diversification Opportunities for Biotechnology Ultrasector and Icon Information

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Biotechnology and Icon is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Icon Information Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icon Information Tec and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Icon Information. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icon Information Tec has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Icon Information go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Icon Information

Assuming the 90 days horizon Biotechnology Ultrasector is expected to generate 1.91 times less return on investment than Icon Information. In addition to that, Biotechnology Ultrasector is 2.54 times more volatile than Icon Information Technology. It trades about 0.04 of its total potential returns per unit of risk. Icon Information Technology is currently generating about 0.17 per unit of volatility. If you would invest  1,490  in Icon Information Technology on May 3, 2025 and sell it today you would earn a total of  165.00  from holding Icon Information Technology or generate 11.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Icon Information Technology

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Icon Information Tec 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Icon Information Technology are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Icon Information may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Biotechnology Ultrasector and Icon Information Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Icon Information

The main advantage of trading using opposite Biotechnology Ultrasector and Icon Information positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Icon Information can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icon Information will offset losses from the drop in Icon Information's long position.
The idea behind Biotechnology Ultrasector Profund and Icon Information Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies